Scilex Holding (SCLXW) Non-Current Assets (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Non-Current Assets of $1.5 million in Q1 2026, up 196.18% quarter-over-quarter from $523000.0 in Q4 2025, and up 1201.68% on a YoY basis from $119000.0 in Q1 2025.

Scilex Holding (SCLXW) Non-Current Assets (2020 - 2026) Analysis & Trends

Scilex Holding's Non-Current Assets history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.

  • In Q1 2026, Non-Current Assets rose 1201.68% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 1201.68% YoY), while the FY2025 annual figure was $523000.0, up 339.5% from the prior year.
  • Non-Current Assets was $1.5 million for Q1 2026 at Scilex Holding, up from $523000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $141.7 million in Q2 2022 to a low of $119000.0 in Q4 2024.
  • Historically, Non-Current Assets has averaged $23.6 million across 5 years, with a median of $944000.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Assets tumbled 99.89% in 2023, then jumped 4814.46% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $944000.0 in 2022, then decreased by 4.98% to $897000.0 in 2023, then slumped by 86.73% to $119000.0 in 2024, then surged by 339.5% to $523000.0 in 2025, then soared by 196.18% to $1.5 million in 2026.
  • The last three Non-Current Assets figures came in at $1.5 million (Q1 2026), $523000.0 (Q4 2025), and $119000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 60.81 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 61.74 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 141.72 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 102.93 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 125.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 61.03 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 37.64 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 165.18 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 59.27 Bn
10 Scilex Holding - - 4.15 Mn 1.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.55 Mn
Dec 31, 2025 523,000.00
Sep 30, 2025 119,000.00
Jun 30, 2025 119,000.00
Mar 31, 2025 119,000.00
Dec 31, 2024 119,000.00
Sep 30, 2024 8.16 Mn
Jun 30, 2024 2.90 Mn
Mar 31, 2024 1.08 Mn
Dec 31, 2023 897,000.00
Sep 30, 2023 166,000.00
Jun 30, 2023 1.14 Mn
Mar 31, 2023 153,000.00
Dec 31, 2022 944,000.00
Sep 30, 2022 101.29 Mn
Jun 30, 2022 141.69 Mn
Mar 31, 2022 140.45 Mn
Dec 31, 2021 538,000.00
Sep 30, 2021 139.41 Mn
Jun 30, 2021 139.41 Mn